Transatlantic ‘powerhouse’ Winston Taylor is set to launch in May 2026, with a particular focus on technology, life sciences ...
New York-based firm makes its second key acquisition in weeks, as the firm pursues growth by broadening its litigation ...
A judge has allowed antitrust claims against the pharma giant to move forward, finding that it plausibly used bundled rebates ...
Melbourne-based firm adds senior attorney with over 25 years of experience in therapeutics, diagnostics and biologics as ...
The new recruit has a “stellar track record” of representing big tech in trade secret and patent litigation, and joins the ...
22 January 2026 New rankings from LSIPR’s sister title spotlight the firms and lawyers that are most successfully navigating ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content. For more information on individual ...
New rankings from LSIPR’s sister title spotlight the firms and lawyers that are most successfully navigating the volatile ...
From public use and foreign sales to the challenges of proving infringement, plant patents present unique legal opportunities ...
Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and ...
27 January 2026 As quantum-enabled innovation accelerates, patentability will hinge on predictability, disclosure, and modality-specific claim drafting in an increasingly unforgiving enablement ...
The court’s review of a high-profile dispute could offer clarity on a grey area for pharma companies and generic drug makers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results